Stephen Streeter
Directeur/Bestuurslid bij Australian Technology Innovation Fund Ltd.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Michael Monsour | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.
Australian Technology Innovation Fund Ltd.
Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | 5 jaar |
Wayne A. Gooley | M | - |
Novus Capital Ltd.
Novus Capital Ltd. Investment Banks/BrokersFinance Novus Capital Ltd. is a stockbroking and share trading service that specializes in capital raising, ASX IPO, corporate advice, reverse takeovers, and M&A. The private company is based in Sydney, Australia. and has subsidiaries in Cayman Islands. The Australian company was founded in 2001 by Wayne A. Gooley, who has been the CEO since 2001. | 23 jaar |
Steve P. Jones | M | - |
Australian Technology Innovation Fund Ltd.
Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | - |
Sara Harman | F | - |
Novus Capital Ltd.
Novus Capital Ltd. Investment Banks/BrokersFinance Novus Capital Ltd. is a stockbroking and share trading service that specializes in capital raising, ASX IPO, corporate advice, reverse takeovers, and M&A. The private company is based in Sydney, Australia. and has subsidiaries in Cayman Islands. The Australian company was founded in 2001 by Wayne A. Gooley, who has been the CEO since 2001. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Peter Corr | M | 76 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 jaar |
Roger Smeed | M | 69 | 2 jaar | |
John Watson Funder | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 jaar |
James Greig | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 5 jaar |
Zoe Yan Zhang | F | 57 | 2 jaar | |
Göran Albert Ando | M | 75 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 jaar |
Dennis J. Feeney | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 7 jaar |
Terje Kalland | M | 73 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 1 jaar |
Thomas Lönngren | M | 73 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | - |
Julia Yan Zhu | F | 59 | 4 jaar | |
Zeng Li | M | 60 | 2 jaar | |
Zhi Qing Vincent Zhu | M | - | 2 jaar | |
Zhou Simon Zhuang | M | - | 2 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Australië | 14 | 82.35% |
China | 3 | 17.65% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Stephen Streeter
- Persoonlijk netwerk